Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Oncotarget|April 30, 2016
Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferationTesa M Severson, Ekaterina Nevedomskaya, Justine Peeters, et al.
Oncogene|May 16, 2018
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitorsKatrien Berns, Joseph J Caumanns, E Marielle Hijmans, et al.
Nucleic Acids Research|April 18, 2023
PAXIP1 and STAG2 converge to maintain 3D genome architecture and facilitate promoter/enhancer contacts to enable stress hormone-dependent transcriptionIsabel Mayayo-Peralta, Sebastian Gregoricchio, Karianne Schuurman, et al.
NPJ Breast Cancer|September 27, 2017
DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trialDenise M Wolf, Christina Yau, Ashish Sanil, et al.
Breast Cancer Research : BCR|August 31, 2017
The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant settingTesa M Severson, Denise M Wolf, Christina Yau, et al.
Molecular Oncology|May 26, 2015
BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potentialTesa M Severson, Justine Peeters, Ian Majewski, et al.
Cancer Cell|November 19, 2019
Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate TumorsParisa Mazrooei, Ken J Kron, Yanyun Zhu, et al.
Haematologica|December 6, 2018
Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all-trans retinoic acid in acute myeloid leukemia across subtypesKimberly N Smitheman, Tesa M Severson, Satyajit R Rajapurkar, et al.
Nature Communications|January 16, 2021
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repairAyesha A Shafi, Chris M McNair, Jennifer J McCann, et al.
Nature|December 10, 2025
Fasting boosts breast cancer therapy efficacy via glucocorticoid activationNuno Padrão, Tesa M Severson, Sebastian Gregoricchio, et al.
Pageof 4